AGARWALEYE - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 2.9
| Stock Code | AGARWALEYE | Market Cap | 14,275 Cr. | Current Price | 450 ₹ | High / Low | 568 ₹ |
| Stock P/E | 242 | Book Value | 61.8 ₹ | Dividend Yield | 0.00 % | ROCE | 5.94 % |
| ROE | 1.31 % | Face Value | 1.00 ₹ | DMA 50 | 480 ₹ | DMA 200 | 464 ₹ |
| Chg in FII Hold | -0.07 % | Chg in DII Hold | -0.14 % | PAT Qtr | 14.6 Cr. | PAT Prev Qtr | 4.95 Cr. |
| RSI | 39.2 | MACD | -16.0 | Volume | 1,64,580 | Avg Vol 1Wk | 3,48,110 |
| Low price | 327 ₹ | High price | 568 ₹ | PEG Ratio | 1.59 | Debt to equity | 0.30 |
| 52w Index | 51.2 % | Qtr Profit Var | 80.3 % | EPS | 1.75 ₹ | Industry PE | 43.3 |
📊 Analysis: AGARWALEYE is trading at 450 ₹, below both its 50 DMA (480 ₹) and 200 DMA (464 ₹), showing weak technical strength. RSI at 39.2 indicates bearish momentum, while MACD (-16.0) confirms negative bias. Current volume (1.64L) is significantly below the 1-week average (3.48L), pointing to weak intraday participation. The setup is risky for intraday trading, with limited upside potential.
💰 Optimal Buy Price: 445–455 ₹ (near support zone)
📈 Profit-Taking Levels: 465–475 ₹ (short-term resistance)
⚠️ Stop-Loss: 438 ₹ (below immediate support)
⏳ If Already Holding: Exit intraday if price fails to sustain above 445 ₹ or if RSI dips further below 38. Book profits near 465–475 ₹ if momentum slows. Watch MACD widening negatively as a clear exit signal.
Positive
- Quarterly PAT improved (14.6 Cr. vs 4.95 Cr.), showing earnings recovery.
- Qtr Profit Var (+80.3%) reflects operational improvement.
- PEG ratio (1.59) indicates reasonable valuation relative to growth.
Limitation
- Extremely high P/E (242) compared to industry average (43.3), suggesting severe overvaluation.
- ROCE (5.94%) and ROE (1.31%) are very weak, showing poor efficiency.
- Trading below both 50 DMA and 200 DMA, showing weak technicals.
- Volume below average, limiting intraday opportunities.
- Dividend yield is 0.00%, offering no income support.
Company Negative News
- No major external negative news reported, but weak fundamentals and FII (-0.07%) and DII (-0.14%) outflows are concerns.
Company Positive News
- Quarterly PAT growth shows earnings rebound.
- EPS turned positive (1.75 ₹), reflecting improvement from prior weakness.
Industry
- Industry P/E at 43.3 is far lower than AGARWALEYE’s P/E (242), highlighting relative overvaluation.
- Healthcare/eye-care sector remains growth-oriented but sensitive to valuations and margins.
Conclusion
🔎 AGARWALEYE is a weak candidate for intraday trading due to bearish momentum, low volume, and stretched valuations. While PAT recovery provides some support, risk outweighs reward. Best strategy: Avoid aggressive intraday positions, only consider small scalps near 445–455 ₹ with strict stop-loss at 438 ₹ and quick exits near 465–475 ₹.